Walleye Trading
IONS icon

Walleye Trading’s Ionis Pharmaceuticals IONS Stock Holding History

Walleye Trading’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,361
Closed -$306K – 4443
2025
Q1 		$282K Sell
9,361
-559
-6% -$18.3K ﹤0.01% 2878
2024
Q4 		$347K Buy
9,920
+6,307
+175% +$236K ﹤0.01% 2882
2024
Q3 		$145K Buy
+3,613
New +$168K ﹤0.01% 3182
2024
Q2 		– Sell
-9,362
Closed -$384K – 4587
2024
Q1 		$406K Buy
9,362
+9,214
+6,226% +$439K ﹤0.01% 2936
2023
Q4 		$7.49K Buy
+148
New +$7.09K ﹤0.01% 4660
2023
Q1 		– Sell
-1,316
Closed -$49.4K – 5090
2022
Q4 		$49.7K Buy
+1,316
New +$55.4K ﹤0.01% 4206
2022
Q1 		– Sell
-10,695
Closed -$325K – 5573
2021
Q4 		$325K Buy
10,695
+1,076
+11% +$33.9K ﹤0.01% 3415
2021
Q3 		$323K Buy
+9,619
New +$362K ﹤0.01% 3394
2021
Q1 		– Sell
-8,612
Closed -$480K – 5017
2020
Q4 		$487K Sell
8,612
-7,423
-46% -$370K ﹤0.01% 2684
2020
Q3 		$761K Buy
16,035
+11,288
+238% +$627K ﹤0.01% 1875
2020
Q2 		$280K Sell
4,747
-28,763
-86% -$1.6M ﹤0.01% 2785
2020
Q1 		$1.58M Buy
33,510
+8,765
+35% +$489K 0.01% 996
2019
Q4 		$1.5M Buy
+24,745
New +$1.47M 0.01% 1445
2019
Q3 		– Sell
-24,299
Closed -$1.58M – 4197
2019
Q2 		$1.56M Buy
24,299
+20,150
+486% +$1.42M 0.01% 1241
2019
Q1 		$337K Sell
4,149
-21,536
-84% -$1.39M ﹤0.01% 2606
2018
Q4 		$1.39M Buy
+25,685
New +$1.31M 0.01% 1376
2018
Q3 		– Sell
-3,279
Closed -$154K – 5402
2018
Q2 		$137K Buy
+3,279
New +$145K ﹤0.01% 3885
2017
Q2 		– Sell
-6,150
Closed -$247 – 4707
2017
Q1 		$247 Buy
+6,150
New +$276K ﹤0.01% 2787
2016
Q2 		– Sell
-50
Closed -$2K – 5513
2016
Q1 		$2K Sell
50
-700
-93% -$28.4K ﹤0.01% 5112
2015
Q4 		$46K Buy
+750
New +$40.5K ﹤0.01% 3915

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's IONS Position: Q2 2025 in Review

Walleye Trading sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 9,361 shares — an estimated $306K sold.

Walleye Trading first reported a position in IONS in Q4 2015 and held it in 20 quarters. The position peaked at $1.58M in Q1 2020. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.

  • Walleye Trading reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 9,361 Ionis Pharmaceuticals shares in Q2 2025, an estimated $306K.
  • Walleye Trading first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 20 quarters.
  • Walleye Trading's Ionis Pharmaceuticals position peaked at $1.58M in Q1 2020.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.